Global Market Size of Nuclear Medicine Or Radiopharmaceuticals Market – 10 Year Market Forecast

Pharmaceuticals

Nuclear Medicine Or Radiopharmaceuticals Market Size Forecast 2022-2029

Nuclear medicine is a medical speciality that uses radioactive tracers (radiopharmaceuticals) in diagnostic imaging and radiotherapy to diagnose and treat disease using special imaging equipment which allows doctors to track the circulation, uptake and excretion of these radioactive tracers. Representing the majority of the market shares and gaining the maximum market revenues, Europe is expected to dominate the market over the forecast period. The market size in 2022 is estimated to be USD 5.16 billion and is expected to grow up to USD 6.89 billion by 2029, registering a CAGR of 4%. The cumulative market size is calculated to be USD 48 billion.

Frequently Asked Questions(FAQ)

• What is Global Market Database?

• The Nuclear Medicine Or Radiopharmaceuticals sector and its changing market trends can be studied using Global Market Database. The market research and intelligence tool studies the shift in line with changing market trends.
• Which are the key regions covered in this report?

• The key regions covered in this report are North America, Europe, APAC, Middle East and ROW.
• Which region is expected to dominate the market by 2029?

• Europe is expected to dominate the market by 2029.
• Which is the largest application segment?

• Endocrine tumours is the largest application segment.
• Which is the smallest segment by type?

• The smallest segment by type is PET radiopharmaceuticals.

Related Markets

• Global Market Size of Pharmaceutical Contract Development and Manufacturing Market – 10 Year Market Forecast
• Global Market Size of Vaccines Market – 10 Year Market Forecast
• Global Market Size of Bioprocess Validation Market – 10 Year Market Forecast
• Global Market Size of Laboratory Filtration Market – 10 Year Market Forecast
• Global Market Size of Blood Culture Test Market – 10 Year Market Forecast